1.Fan, JG (2013) Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol 28, Suppl. 1, 11–17.
2.Fabbrini, E, Sullivan, S & Klein, S (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51, 679–689.
3.Han, X, Liu, C, Xue, Yet al. (2016) Long-term fatty liver-induced insulin resistance in orotic acid-induced nonalcoholic fatty liver rats. Biosci Biotechnol Biochem 80, 735–743.
4.de Wit, NJ, Afman, LA, Mensink, Met al. (2012) Phenotyping the effect of diet on non-alcoholic fatty liver disease. J Hepatol 57, 1370–1373.
5.Hernandez-Rodas, MC, Valenzuela, R & Videla, LA (2015) Relevant aspects of nutritional and dietary interventions in non-alcoholic fatty liver disease. Int J Mol Sci 16, 25168–25198.
6.Sacks, FM, Svetkey, LP, Vollmer, WMet al. (2001) Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 344, 3–10.
7.Parikh, A, Lipsitz, SR & Natarajan, S (2009) Association between a DASH-like diet and mortality in adults with hypertension: findings from a population-based follow-up study. Am J Hypertens 22, 409–416.
8.Ma, J, Fox, CS, Jacques, PFet al. (2015) Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts. J Hepatol 63, 462–469.
9.Huh, JH, Lee, KJ, Lim, JSet al. (2015) High dietary sodium intake assessed by estimated 24-h urinary sodium excretion is associated with NAFLD and hepatic fibrosis. PLoS One 10, e0143222.
10.Shirani, F, Salehi-Abargouei, A & Azadbakht, L (2013) Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: a systematic review and meta-analysis on controlled clinical trials. Nutrition 29, 939–947.
11.Soltani, S, Chitsazi, MJ & Salehi-Abargouei, A (2018) The effect of Dietary Approaches to Stop Hypertension (DASH) on serum inflammatory markers: a systematic review and meta-analysis of randomized trials. Clin Nutr 37, 542–550.
12.Asemi, Z & Esmaillzadeh, A (2015) DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial. Horm Metab Res 47, 232–238.
13.Shenoy, SF, Poston, WS, Reeves, RSet al. (2010) Weight loss in individuals with metabolic syndrome given DASH diet counseling when provided a low sodium vegetable juice: a randomized controlled trial. Nutr J 9, 8.
14.Hekmatdoost, A, Shamsipour, A, Meibodi, Met al. (2016) Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of nonalcoholic fatty liver disease. Int J Food Sci Nutr 67, 1024–1029.
15.Razavi Zade, M, Telkabadi, MH, Bahmani, Fet al. (2016) The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial. Liver Int 36, 563–571.
16.Liu, J, Shi, WQ, Cao, Yet al. (2014) Higher serum carotenoid concentrations associated with a lower prevalence of the metabolic syndrome in middle-aged and elderly Chinese adults. Br J Nutr 112, 2041–2048.
17.Wang, C, Lin, X-L, Fan, Y-Yet al. (2016) Diet quality scores and risk of nasopharyngeal carcinoma in Chinese adults: a case–control study. Nutrients 8, 112.
18.Zhang, CX & Ho, SC (2009) Validity and reproducibility of a food frequency questionnaire among Chinese women in Guangdong province. Asia Pac J Clin Nutr 18, 240–250.
19.Yang, YX, Wang, GY & Pan, XC (2002) China Food Composition Table. Beijing: Peking University Medical Press.
20.Fung, TT, Chiuve, SE, McCullough, MLet al. (2008) Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med 168, 713–720.
21.Willett, WC, Howe, GR & Kushi, LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65, 1220S–1228S; discussion 1229S–1231S.
22.Zeng, MD, Fan, JG, Lu, LGet al. (2008) Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis 9, 108–112.
23.Balagopal, P, Graham, TE, Kahn, BBet al. (2007) Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 92, 1971–1974.
24.Yao-Borengasser, A, Varma, V, Bodles, AMet al. (2007) Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 92, 2590–2597.
25.Sugiura, M, Nakamura, M, Ikoma, Yet al. (2006) The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects. J Epidemiol 16, 71–78.
26.Attard, SM, Howard, AG, Herring, AHet al. (2015) Differential associations of urbanicity and income with physical activity in adults in urbanizing China: findings from the population-based China Health and Nutrition Survey 1991–2009. Int J Behav Nutr Phys Act 12, 152.
27.Ainsworth, BE, Haskell, WL, Herrmann, SDet al. (2011) 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc 43, 1575–1581.
28.He, Y, Zhai, F, Ma, Get al. (2009) Abdominal obesity and the prevalence of diabetes and intermediate hyperglycaemia in Chinese adults. Public Health Nutr 12, 1078–1084.
29.Straus, J, Chang, H & Hong, C-Y (2016) An exploratory path analysis of attitudes, behaviors and summer water consumption in the Portland Metropolitan Area. Sustain Cities Soc 23, 68–77.
30.Yki-Jarvinen, H (2014) Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2, 901–910.
31.Enriori, PJ, Evans, AE, Sinnayah, Pet al. (2007) Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab 5, 181–194.
32.Lambert, JE, Ramos-Roman, MA, Browning, JDet al. (2014) Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146, 726–735.
33.Wijarnpreecha, K, Thongprayoon, C, Edmonds, PJet al. (2016) Associations of sugar- and artificially sweetened soda with nonalcoholic fatty liver disease: a systematic review and meta-analysis. QJM 109, 461–466.
34.Yilmaz, B, Sahin, K, Bilen, Het al. (2015) Carotenoids and non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr 4, 161–171.
35.Cao, Y, Wang, C, Liu, Jet al. (2015) Greater serum carotenoid levels associated with lower prevalence of nonalcoholic fatty liver disease in Chinese adults. Sci Rep 5, 12951.
36.Asemi, Z, Samimi, M, Tabassi, Zet al. (2014) Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial. Nutrition 30, 1287–1293.
37.Chiu, S, Bergeron, N, Williams, PTet al. (2016) Comparison of the DASH (Dietary Approaches to Stop Hypertension) diet and a higher-fat DASH diet on blood pressure and lipids and lipoproteins: a randomized controlled trial. Am J Clin Nutr 103, 341–347.
38.Guo, Y-C, Zhou, Y, Gao, Xet al. (2018) Association between nonalcoholic fatty liver disease and carotid artery disease in a community-based Chinese population: a cross-sectional study. Chin Med J 131, 2269–227.